RT Conference Proceedings
T1 Early clinical experience with trifluridine/tipiracil for refractory metastatic colorectal cancer: The ROS study.
A1 Garcia-Alfonso, Pilar
A1 Munoz Martin, Andres J.
A1 Jimenez-Castro, Jeronimo
A1 Jimenez-Fonseca, Paula
A1 Pericay, Carles
A1 Longo, Federico
A1 Reyna, Carmen
A1 Argiles, Guillem
A1 Gonzalez Astorga, Beatriz
A1 Jose Gomez-Reina, Maria
A1 Ruiz Casado, Ana
A1 Rodriguez-Salas, Nuria
A1 Lopez-Lopez, Rafael
A1 Carmona Bayonas, Alberto
A1 Conde-Herrero, Veronica
A1 Aranda, Enrique
PB Lippincott williams & wilkins
SN 0732-183X
YR 2021
FD 2021-05-20
LK https://hdl.handle.net/10668/25274
UL https://hdl.handle.net/10668/25274
LA en
DS RISalud
RD Apr 7, 2025